By Alizeh Siddiqui
After some members expressed reservations, the Iowa Pharmacy Board decided on Wednesday to delay its decision on marijuana’s drug classification until January.
A board subcommittee initially recommended that the entire board consider reclassifying the substance from a Schedule I drug to a Schedule II drug. The recommendation was based on marijuana’s use for medical purposes, bolstered by a new law in Iowa that made the use of CBD oil, which is derived from the marijuana plant, legal for the treatment of children with epilepsy.
An Iowa Pharmacy Board member and pharmacist from Monona, Edward Maier, read the subcommittee’s recommendation: